Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alpha-synuclein
Alzheimer's disease
amantadine
anosmia
asymptomatic
atypical
autonomic dysfunction
basal ganglia, infarction
basal ganglia, lesion of
biologic markers
bladder dysfunction
brainstem, vascular malformation of
carotid artery disease
carotid artery disease, asymptomatic
carotid artery disease, medical management
carotid artery stenosis
CAT scan, emission
CAT scan, emission, abnormal
cavernous hemangioma
cerebellar hemorrhage
cerebral cortical atrophy
cerebral infarction
cerebral infarction, subcortical
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular disease
cerebrovascular disease, surgical treatment of
ceruloplasmin, serum
chorea
choreoathetosis
cognition
complications
consanguinity
constipation
controversies in neurology
copper metabolism, abnormal
delay in diagnosis
dementia
dementia, age at onset
deprenyl
depression
developmental venous anomalies
diagnostic criteria
diet
dopamine agonist
dopamine receptor
Durett hemorrhages
dysexecutive syndrome
dyskinesia
dystonia
endarterectomy, carotid
enzyme inhibition
familial
gait disorder
gene
gene mutation
genetic neurologic disorders
genetic screening
globus pallidus
globus pallidus, lesion of
globus pallidus, lesion of, bilateral
gray matter
hallucination
hallucination, visual
head injury
head injury, severe
headache
hepatic failure
hepatolenticular degeneration(Wilson's disease)
heralding manifestation
hormone replacement
human genome
Huntington's chorea
Huntington's chorea, presymptomatic detection of
hyperosmia
hypersomnia
hyposmia
imbalance
incidental finding
industrial neurologic disorders
intellectual deficit
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, recurrent
Kayser-Fleischer ring
L-dopa
L-dopa, drug interactions with and side effects of
Lewy body
Lewy body disease, diffuse
liver disease
malformation, vascular
malformation, vascular, cerebral
manganese intoxication
mild cognitive impairment
misdiagnosis
monoamine oxidase inhibitors
mortality
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, diffusion tensor
MRI, functional
MRI, incidental finding
MRI, susceptibility weighted
multiple sclerosis
myoclonus
neuroleptic, atypical
neurologic disease, diagnoses of
neurologic examination, focal
neurologic symptoms
neuropathology
neuroprotective agents
neurotoxic
neurotoxin
occupational neurologic disorders
orthostatic hypotension
Parkinson disease
Parkinson disease, acute onset
Parkinson disease, arteriosclerotic
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, mode of onset
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, presymptomatic detection
Parkinson disease, prognosis of
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism syndrome
penicillamine
pergolide
pramipexole
preclinical
premarin
prevention of neurologic disorders
PRKN gene
prognosis
psychiatric problems in neurologic disorders
psychological testing, neurologic problems
psychosis
quetiapine
radiation therapy, stereotactic
radiotracer imaging
rasagiline
REM sleep
REM sleep behavior disorder
revascularization, surgical
review article
risk factors
salivation, excessive
seizure
seizure, intractable
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
Smell Identification Test
solvent
stereotaxic surgery
stimulation, deep brain
substantia nigra
syncope
synucleinopathy
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
trichloroethylene
ultraprocessed foods
visuospatial disturbance
walking, difficulty with
watershed infarcts
welder
Showing articles 200 to 250 of 2254 << Previous Next >>

Screening for Asymptomatic Carotid Artery Stenosis
JAMA 313:192-193,212, Weyer, G.W. & Davis. A.M., 2015

Clinicopathologic Conference, Frontotemporal Lobar Degeneration with Tau-positive Inclusions (Picks Disease Subtype) Due to a Gly389Arg MAPT Mutation, Resulting in the Behavioral Variant of Frontotemporal Dementia with Parkinsonism
NEJM 372:1151-1162, Miller, B.L.,et al, 2015

Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An IOM Report on Redefining an Illness
JAMA 313:1101-1102, Clayton, E.W., 2015

Comparing 3T and 1.5T MRI for Mapping Hippocampal Atrophy in the Alzheimers Disease Neuroimaging Initiative
AJNR 36:653-660, Chow, N.,et al, 2015

Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015

Intracranial Dural Arteriovenous Fistulae
Stroke 46:2017-2025, Miller, T.R. & Gandhi, D., 2015

Parkinsons Disease Beyond 20 Years
JNNP 86:849-855, Cilia, R.,et al, 2015

A 56-year-old Man with Cognitive Impairment and Difficulty Tying his Necktie
Neurol 85:e116-e122, Baker, J.M.,et al, 2015

Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis
Stroke 46:3288-3301, Abbott, A.L.,et al, 2015

Non-Alzheimers Dementia 1 Frontotemporal Dementia
Lancet 386:1672-1682, Bang, Jee.,et al, 2015

Asymptomatic Atrial Fibrillation
JAMA 314:1911-1912, Freedman, S.B. & Lowres, N., 2015

Are the Current Risks of Asymptomatic Carotid Stenosis Exaggerated?
JAMA Neurol 72:1233-1234, Chaturvedi, S. & Sacco, R.L., 2015

Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of DIagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality
AJNR 36:2010-2016, Noh, Y.,et al, 2015

Diffusion-Weighted Imaging in Transient Neurological Attacks
Ann Neurol 78:1005-1010, Van Rooij, F.G.,et al, 2015

Deep Brain Stimulation of the Dentate Nucleus Improves Cerebellar Ataxia After Cerebellar Stroke
Neurol 85:2075-2076, Teixeira, M.J.,et al, 2015

Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014

Long-Term Clinical Outcomes After Fetal Cell Transplantation in Parkinson Disease Implications for the Future of Cell Therapy
JAMA 311:617-618, Bega, D. & Krainc, D., 2014

Neurologic Complications in Dengue Virus Infection
Neurol 83:1601-1609,1590, Sahu, R.,et al, 2014

Deep-Brain Stimulation - Entering the Era of Human Neural-Network Modulation
NEJM 371:1369-1373, Okun, M.S., 2014

The Diagnosis and Management of Mild Cognitive Impairment
JAMA 312:2551-2561, Langa, K.M. & Levine, D.A., 2014

Restless Genital Syndrome in Parkinson Disease
JAMA Neurol 71:1559-1561, Aquino, C.C.,et al, 2014

Degenerative Diseases of the Nervous System, Alzheimer Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1063, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Multiple System Atrophy
Adams & Victors Principles of Neurology, Chp 39, pg 1095, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Progressive Supranuclear Palsy
Adams & Victors Principles of Neurology, Chp 39, pg 1096, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Dystonia Musculorum Deformans
Adams & Victors Principles of Neurology, Chp 39, pg 1099, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Olivopontocerebellar Atrophy
Adams & Victors Principles of Neurology, Chp 39, pg 1106, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Machado-Joseph-Azorean Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1107, Ropper, A.H.,et al, 2014

The Acquired Metabolic Disorders of the Nervous System, Carbon Monoxide Poisoning
Adams & Victors Principles of Neurology Chp 40, pg 1138, Ropper, A.H.,et al, 2014

Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Antipsychosis Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1208, Ropper, A.H.,et al, 2014

Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Monoamine Oxidase Inhibitors
Adams & Victors Principles of Neurology Chp 43, pg 1210, Ropper, A.H.,et al, 2014

Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Encephalitis Lethargica (non Economo Disease, sleeping sickness)
Adams & Victors Principles of Neurology, Chp 33, pg 768, Ropper, A.H.,et al, 2014

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Parkinsonism and Midbrain Syndromes with Hydrocephalus and Shunting
Adams & Victors Principles of Neurology, Chp 30, pg 627, Ropper, A.H.,et al, 2014

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Intracranial Hypotension
Adams & Victors Principles of Neurology, Chp 30, pg 632, Ropper, A.H.,et al, 2014

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Neurosyphilis
Adams & Victors Principles of Neurology, Chp 32, pg 723, Ropper, A.H.,et al, 2014

Intracranial Neoplasms and Paraneoplastic Disorders, Meningioma
Adams & Victors Principles of Neurology, Chp 31, pg 656, Ropper, A.H.,et al, 2014

Inherited Metabolic Diseases of the Nervous System, Hepatolenticular Degeneration (Wilson Disease)
Adams & Victors Principles of Neurology, Chp 37, pg 982, Ropper, A.H.,et al, 2014

Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014

Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis
NEJM 370:792-794, McMinn, P.C., 2014

Clinical Characteristics and Outcome of Brain Abscess
Neurol 82:806-813, Brouwer, M.C.,et al, 2014

Tremor
JAMA 311:948-954, Elias, W.J. & Shah, B.B., 2014

Giant Cell Arteritis
Lancet 383:1182, McAlinden, C.,et al, 2014

Long-Term Safety and Tolerability of ProSavin, a Lentiviral Vector-Based Gene Therapy for Parkinsons Disease: A Dose Escalation, Open-Label, Phase 1/2 Trial
Lancet 383:1138-1146,1107, Palfi, S.,et al, 2014

Parkinson Disease Subtypes
JAMA 71:499-504, Thenganatt, M. & Jankovic, J., 2014

Skin Nerve (-Synuclein Deposits
Neurol 82:1362-1369, Donadio, V.,et al, 2014

Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014

Multidisciplinary Consensus on Assessment of Unruptured Intracranial Aneurysms
Stroke 45:1523-1530, Etminan, N.,et al, 2014

Venous Thromboembolism in Amyotrophic Lateral Sclerosis
Neurol 82:1674-1677, Gladman, M.,et al, 2014

Sickle Cell Disease and Stroke
Stroke 45:e98-e100, Talahma, M.,et al, 2014

Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial
Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014



Showing articles 200 to 250 of 2254 << Previous Next >>